Log in to your IBTimes Account

close
ID
Password

FTSE 100 edges up



23 October 2006 @ 05:03 am BST

London - The FTSE 100 edged up on Monday, led by Standard Chartered in a quiet market enlivened by bid speculation and a strong rally in Japan's Nikkei index.


The outside of the London Stock Exchange is seen in the City of London, March 7, 2005. The FTSE 100 is seen opening up 13-23 points on Monday, said financial bookmakers, after the index closed down 0.8 points at 6,155.2 on Friday. REUTERS/Toby Melville
The outside of the London Stock Exchange is seen in the City of London, March 7, 2005. The FTSE 100 is seen opening up 13-23 points on Monday, said financial bookmakers, after the index closed down 0.8 points at 6,155.2 on Friday. REUTERS/Toby Melville
1 of 1

Standard Chartered rose 2.2 percent on Monday after weekend media reports that Dubai government agency Istithmar might raise its stake in the Asia focused bank. There were also reports the bank could take over Singapore's DBS Group Holdings, Southeast Asia's biggest bank.

The FTSE 100 rose 5.6 points, or 0.1 percent, to 6,160.8 by 8:39 a.m. It closed down 8 points on Friday at 6,155.2 despite reaching a record intraday high of 6,199.88.

"Everybody's looking for the next bid," said Martin Slaney, head of spread betting, GFT Global Markets.

"The market is otherwise being driven by the U.S., which looks as if it has shaken off the disappointing earnings from Caterpillar," he said.

"So long as we continue to see decent earnings, we could see the FTSE 100 rise to the next resistance level of 6,200 and break new records this week."

Among financials, Prudential rose 1 percent after UBS upped its target price on the stock. The insurer's chief executive has been set a five month deadline by investors to turn round the business, the Sunday Telegraph reported, citing sources close to institutional investors.

Pharmaceuticals were strong. GlaxoSmithKline rose 0.2 percent after it said on Friday it won approval to sell a new once a day formulation of its Coreg hypertension drug.

AstraZeneca rose 0.4 percent after the FDA on Friday approved its Seroquel bipolar depression treatment.

Intercontinental tacked on 0.6 percent after announcing a new venture to operate 31 hotels in Japan.

Copyright 2009 Thomson Reuters. All rights reserved.

    Click!
  • Rate this article:

advertisement
advertisement
 
 
IBTimes © 2012 IBTimes Company. All Rights Reserved. Partners